BCBH Law is supporting via sponsorship the 2025 International Conference of the International Mesothelioma Interest Group (iMig) from October 26-29 in Philadelphia, PA. Head lawyer Angela C. Bullock will attend the event as representation of the mesothelioma and asbestos law firm.
The International Conference of the iMig is bi-annual (every two years), bringing scientists, patient advocates and clinicians together to collaborate in the fight against mesothelioma. A rare cancer, mesothelioma spreads rapidly in the body and usually gives patients poor life expectancy. Doctors, researchers, and patient advocates rely on the iMig conference to improve treatment and patient care for better outcomes.
Angela began her asbestos litigation career in 1996 and has since successfully represented thousands of asbestos victims. As a mesothelioma lawyer, she continues to fight for the rights of mesothelioma and lung cancer victims — and their families. Angela will be attending as an experienced advocate to learn more about cutting-edge medicine to fight mesothelioma and other emerging trends to better serve the firm’s clients.
The conference takes place at the Philadelphia Marriott Downtown and features seven anticipated plenary sessions. Smaller sessions feature world-class specialists for mesothelioma, experts, the latest research involving treatment approaches and patient care.
The keynote speaker is Stephen Hahn, MD, chief executive officer at Nucleus RadioPharma. He’s the former U.S. commissioner of Food and Drugs and President and CEO of MD Anderson Cancer Center in Houston, TX.
Some of the plenary speakers are:
- Aaron Mansfield, MD, a medical oncologist and mesothelioma specialist at the Mayo Clinic
- Jenette Creaney, PhD, a molecular biologist from the University of Western Australia
- Paul Baas, a senior staff member in the department of Thoracic Oncology at the Netherlands Cancer Institute in Amsterdam
- Andrea Wolf, MD, a mesothelioma specialist at Mount Sinai
- Michele Carbone, MD, PhD, a researcher specializing in mesothelioma at Hawaii Cancer Center
- Raphael Bueno, MD, the Chief of the Division of Thoracic Surgery and head of the International Mesothelioma Program at Brigham and Women’s Hospital
- Raffit Hassan, MD, the Senior Investigator of Thoracic and Gastrointestinal Malignancies at the National Cancer Institute
- Patrick Forde, MD, the Director of Thoracic Oncology Clinical Research at the Sidney Kimmel Comprehensive Cancer Center
- Hedy Lee Kindler, MD, the Director of the Mesothelioma Program at the University of Chicago Comprehensive Cancer Center
- Daniel Sterman, MD, an interventional pulmonologist at NYU Langone Health Perlmutter Cancer Center
- Joseph Friedberg, MD, Co-Director of Temple Health Mesothelioma and Pleural Disease Program at Temple University Health System’s Fox Chase Cancer Center
The theme for the conference is “Fostering Global Collaboration”, which highlights iMig’s mission to advance research, treatment, and prevention of mesothelioma.
BCBH Law is sponsoring the event through Mesothelioma Guide, which is the patient advocacy and patient education arm of the firm. Mesothelioma Guide is dedicated to fighting this rare cancer through educating patients and caregivers of top therapies, how to connect with specialists, and focusing on quality of life.
Learn more about the iMig conference on the event website.
Categories: